Drug
Arhalofenate clinical trials
Also written MBX-102.
- studies test it
- 6
- open now
- 0
- in phase 3
- 1
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
6 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2014 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 6
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
- Gout
- 3
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses arhalofenate is read from its arms, and is right about nine times in ten.
Testing it · 6
- Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With GoutCompletedPhase 2Gilead SciencesNCT01336686Written as Arhalofenate
- Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With GoutCompletedPhase 2Gilead SciencesNCT02252835Written as Arhalofenate
- Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on MetforminTerminatedPhase 2Gilead SciencesNCT00814372Written as MBX-102
- Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout PatientsCompletedPhase 2Gilead SciencesNCT02063997Written as Arhalofenate 600 mg
- Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on InsulinCompletedPhase 2/3Gilead SciencesNCT00353587Written as MBX-102
- Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout PatientsCompletedPhase 2Gilead SciencesNCT01416402Written as Arhalofenate
Given in every arm · 1 — arhalofenate is usual care beside what is tested
Codes
What other systems call arhalofenate · ClinicalTrials.gg INT000130
- MeSH (NLM) C000593473arhalofenateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 1P01UJR9X1ARHALOFENATEConfirmed FDA, NLM, Wikidata
- Wikidata Q653074arhalofenateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83536ArhalofenateOne source FDA
- DrugBank DB11811One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000593473 | arhalofenate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 1P01UJR9X1 | ARHALOFENATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q653074 | arhalofenate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83536 | Arhalofenate | One source FDA |
| DrugBank | DB11811 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.